Results 171 to 180 of about 191,503 (337)

The use of time consecrated to the realization of individual activities as a parameter to allocate resources cost to activities in Activity Based Costing [PDF]

open access: yes
In the paper the possibilities of using the time spent on realization of individual activities as a parameter for allocating the costs of resources to activities in Activity Based Costing are presented.
Dorota Kuchta, Michal Kowalski
core  

Clinical Practice Guideline for Evaluation and Management of Peripheral Nervous System Manifestations in Sjögren's Disease

open access: yesArthritis Care &Research, EarlyView.
Objective Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies.
Anahita Deboo   +88 more
wiley   +1 more source

Intravenous versus subcutaneous immunoglobulin in patients with haematological malignancies: time-driven activity-based costing. [PDF]

open access: yesSupport Care Cancer
de Albornoz SC   +16 more
europepmc   +1 more source

Is it possible to automate the discovery of process maps for the time-driven activity-based costing method? A systematic review. [PDF]

open access: yesBMC Health Serv Res, 2023
Iachecen F   +4 more
europepmc   +1 more source

Activity based costing as tool of controlling [PDF]

open access: yes
У роботі розглянуто метод функціонально-вартісного аналізу, проаналізовано його переваги та недоліки. Запропоновано порівняльний аналіз традиційної системи обліку витрат та функціонально-вартісного аналізу.Abstract considers the activity-based costing ...
Grygorash, Iryna   +1 more
core   +1 more source

Combining Three Peripheral Blood Biomarkers to Stratify Rheumatoid Arthritis–Associated Interstitial Lung Disease Risk

open access: yesArthritis Care &Research, EarlyView.
Objective The purpose was to evaluate a biomarker score consisting of MUC5B rs35705950 promoter variant, plasma matrix metalloproteinase‐7 (MMP‐7), and serum anti–malondialdehyde‐acetaldehyde (anti‐MAA) antibody for rheumatoid arthritis (RA)–associated interstitial lung disease (ILD) risk stratification.
Kelsey Coziahr   +16 more
wiley   +1 more source

Addressing Economic Insecurities Can Improve Patient‐Reported Outcomes in Lupus

open access: yesArthritis Care &Research, EarlyView.
Objective Economic insecurities, such as food, housing, transportation, and financial challenges, are modifiable risk factors and influence patient‐reported outcomes (PROs) in systemic lupus erythematosus (SLE). We examined the following: (1) associations between economic insecurities and PROs, and (2) the impact of screening and addressing economic ...
Jay Patel   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy